Prevalence, awareness, characteristics, and health outcomes associated with COPD at-risk status among adults in Japan

References

• Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–365.
   PubMed Web of Science ®Google Scholar
• Santos SR, Lizzi ES, Vianna EO. Characteristics of undiagnosed COPD in a senior community center. Int J Chron Obstruct Pulmon Dis. 2014;9:1155–1161.
   PubMed Web of Science ®Google Scholar
• World Health Organization. World Health Statistics 2008. Geneva: WHO; 2008.
   Google Scholar
• Landis SH, Muellerova H, Mannino DM, et al. Continuing to confront COPD international patient survey: methods, COPD prevalence, and disease burden in 2012–2013. Int J Chron Obstruct Pulmon Dis. 2014;9:597–11.
   PubMed Web of Science ®Google Scholar
• Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD epidemiology study. Respirology. 2004;9:458–465.
   PubMed Web of Science ®Google Scholar
• Shibata Y, Inoue S, Igarashi A, et al. A lower level of forced expiratory volume in 1 second is a risk factor for all-cause and cardiovascular mortality in a Japanese population: the Takahata study. PLoS ONE. 2013;8:e83725.
   Google Scholar
• Grouse L, Nonikov D. The global battle to improve patients’ health outcomes: COPD awareness, activities, and progress. J Thorac Dis. 2014;6:161–168.
   PubMed Web of Science ®Google Scholar
• Horie J, Murata S, Hayashi S, et al. Factors that delay COPD detection in the general elderly population. Respir Care. 2011;56:1143–1150.
   PubMed Web of Science ®Google Scholar
• Elbehairy AF, Ciavaglia CE, Webb KA, et al. Pulmonary gas exchange abnormalities in mild COPD: implications for dyspnea and exercise intolerance. Am J Respir Crit Care Med. 2015: published online 31 March 2015. doi:10.1164/rccm.201501-0157OC.
   Web of Science ®Google Scholar
• Jones PW, Brusselle G, Dal Negro RW, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med. 2011;105:57–66.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. MMWR. 2002;51(SS06):1–16.
   Google Scholar
• De Marco R, Accordini S, Marcon A, et al. Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am J Respir Crit Care Med. 2011;183:891–897.
   PubMed Web of Science ®Google Scholar
• Kalhan R, Arynchyn A, Colangelo L, et al. Lung function in young adults predicts airflow obstruction 20 years later. Am J Med. 2010;123:468, e1–7.
   Web of Science ®Google Scholar
• Nishimura S, Zaher C. Cost impact of COPD in Japan: opportunities and challenges? Respirology. 2004;9:466–473.
   PubMed Web of Science ®Google Scholar
• DiBonaventura MD, Paulose-Ram R, Su J, et al. The burden of chronic obstructive pulmonary disease among employed adults. Int J Chron Obstruct Pulmon Dis. 2012;7:211–219.
   PubMed Web of Science ®Google Scholar
• Tsuda T, Suematsu R, Kamohara K, et al. Development of the Japanese version of the COPD Assessment Test. Respir Investig. 2012;50:34–39.
   PubMedGoogle Scholar
• Onishi K, Yoshimoto D, Jones PW. Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan. Int J Chron Obstruct Pulmon Dis. 2014;9:563–568.
   PubMed Web of Science ®Google Scholar
• Watanabe R, Tanaka T, Aita K, et al. Osteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary function. J Bone Miner Metab. 2014: published online 5 July 2014. doi:10.1007/s00774-014-0605-7.
   Web of Science ®Google Scholar
• Horie M, Noguchi S, Tanaka W, et al. Relationships among smoking habits, airflow limitations, and metabolic abnormalities in school workers. PLoS ONE. 2013;8:e81145.
   Google Scholar
• Horita N, Kaneko T, Shinkai M, et al. Depression in Japanese patients with chronic obstructive pulmonary disease: a cross-sectional study. Respir Care. 2013;58:1196–03.
   PubMed Web of Science ®Google Scholar
• Iguchi A, Senjyu H, Hayashi Y, et al. Relationship between depression in patients with COPD and the percent of predicted FEV1, BODE index, and health-related quality of life. Respir Care. 2013;58:334–339.
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Nakamura H, Chubachi S, et al. Analysis of comorbid factors that increase the COPD assessment test scores. Respir Res. 2014;15:13.
   PubMed Web of Science ®Google Scholar
• Ko FWS, Hui DSC, Lai CKW. Worldwide burden of COPD in high- and low-income countries. Part III. Asia-Pacific studies. Int J Tuberc Lung Dis. 2008;12:713–717.
   PubMed Web of Science ®Google Scholar
• Eriksen M, Mackay J, Schluger N, et al. The tobacco atlas. 5th ed. Atlanta, GA: American Cancer Society; 2015.
   Google Scholar
• Jamrozik E, Musk AW. Respiratory health issues in the Asia-Pacific region: an overview. Respirology. 2011;16:3–12.
   PubMed Web of Science ®Google Scholar
• Yawn BP, Mapel DW, Mannino DM, et al. Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction. Int J Chron Obstruct Pulmon Dis. 2010;5:1–10.
   PubMedGoogle Scholar
• Dalal AA, DeMuro-Mercon C, Lewis S, et al. Validation of alternate modes of administration of the lung function questionnaire (LFQ) in subjects with smoking history. Int J Chron Obstruct Pulmon Dis. 2010;5:425–434.
   PubMedGoogle Scholar
• Hanania NA, Mannino DM, Yawn BP, et al. Predicting risk of airflow obstruction in primary care: validation of the Lung Function Questionnaire (LFQ). Respir Med. 2010;104:1160–1170.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
   PubMedGoogle Scholar
• De Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS ONE. 2013;8:e62985.
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34:648–654.
   PubMed Web of Science ®Google Scholar
• Maruish ME, Ed. User’s manual for the SF-36v2 health survey. 3rd ed. Lincoln, RI: Quality Metric Incorporated; 2011.
   Google Scholar
• Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271–292.
   PubMed Web of Science ®Google Scholar
• Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14:1523–1532.
   PubMed Web of Science ®Google Scholar
• Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353–365.
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Yanai M, Hanagama M, et al. The burden of chronic obstructive pulmonary disease in the elderly population. Respir Investig. 2014;52:296–01.
   PubMedGoogle Scholar
• Zhou Y, Wang D, Liu S, et al. The association between BMI and COPD: the results of two population-based studies in Guangzhou, China. COPD. 2013;10:567–724.
   PubMedGoogle Scholar
• Sekine Y, Fujisawa T, Suzuki K, et al. Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba chronic obstructive pulmonary disease lung cancer screening study group. Respirology. 2014;19:98–04.
   PubMed Web of Science ®Google Scholar
• Sekine Y, Yanagibori R, Suzuki K, et al. Surveillance of chronic obstructive pulmonary disease in high-risk individuals by using regional lung cancer mass screening. Int J Chron Obstruct Pulmon Dis. 2014;9:647–656.
   PubMed Web of Science ®Google Scholar
• Nelson SB, LaVange LM, Nie Y, et al. Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population. Chest. 2012;142:358–366.
   PubMed Web of Science ®Google Scholar
• Nishimura K, Mitsuma S, Kobayashi A, et al. COPD and disease-specific health status in a working population. Respir Res. 2013;14:61.
   PubMed Web of Science ®Google Scholar